NDRA · ENDRA Life Sciences Inc.
The AI's read
The biggest concern is that an ASPI affiliate can now use its share-purchase rights without the earlier ownership limit. If it uses them, ENDRA could issue more shares, leaving current owners with a smaller part of the company. Some shares still need stockholder approval before they can be issued. The merger terms remain in force, and Renergen may borrow more from ASPI. Those changes may help the deal move ahead, but they do not remove the added share-issuance risk.